Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
May 14, 2007

BioServe and Seegene to Develop Detection System for Infectious Diseases in India

  • BioServe and Seegene inked a partnership to develop, validate, and service new test systems for a variety of infectious diseases in the Indian market.

    Through this partnership, Seegene will access BioServe's repository of Indian DNA samples to develop tools to test for illnesses such as sexually transmitted diseases, tuberculosis, and HIV.

    BioServe will offer diagnostic testing services using Seegene's Seeplex™ STD detection system for Mycoplasma hominis, Ureaplasma urealyticum, Neisseria gonorrhoeae, Chlamydia trachomatis, Herpes Simplex Virus 2, and HPV. All of the test systems are based on Seegene's DPO™ technology.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »